research

Long term efficacy, safety and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort

Authors
Publication date
28 March 2018
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    K

      Similar works

      Full text

      thumbnail-image

      Available Versions

      DEA University of Debrecen Electronic Archive

      redirect
      oaioai:dea.lib.unideb.hu:2437/242...
      Last time updated on 12/09/2018